Vishal Shete

Vishal Shete

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MMManoj Vasant Murhekar
Manoj Vasant Murhekar
VJVasna Joshua
Vasna Joshua
KKK. Kanagasabai
K. Kanagasabai
VSVishal Shete
Vishal Shete
MRM. Ravi
M. Ravi
SMSanjay Mehendale
Sanjay Mehendale
The Indian Council of Medical Research and the Department of Health Research have established a network of Virus Research and Diagnostic Laboratories (VRDL) to strengthen laboratory capacity in India. We analyzed the data generated by the 52 VRDLs during 2014-2017 to describe the epidemiology of dengue fever (DF) in India. As per the laboratory protocol, suspected DF patients reporting to various hospitals where VRDLs are located, or samples from suspected DF outbreaks are investigated for the presence of NS1 antigen or IgM antibodies against dengue. The data were analyzed to describe the distribution of DF by time (month and year), place (district and state) and person (age and sex) characteristics. Between 2014-2017, VRDLs investigated 211,432 suspected DF patients, 28.4% of whom were serologically confirmed. The median age of dengue positive patients was 25 years (IQR: 16-36). Dengue positivity was significantly higher among males. The mean monthly dengue positivity ranged from 7.7% to 37%, with higher positivity reported during September and October months. VRDLs provided diagnosis to 190 suspected outbreaks. The data from the VRDL network indicate dengue was the etiology in one-fourth of AFI cases. Dengue was the second commonest etiology of suspected outbreaks diagnosed by VRDLs.

3 October 2018 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MMManoj V Murhekar
Manoj V Murhekar
MAM Ashok
M Ashok
KKK Kanagasabai
K Kanagasabai
VJVasna Joshua
Vasna Joshua
MRM Ravi
M Ravi
SMSanjay M Mehendale
Sanjay M Mehendale
Hepatitis A and hepatitis E viruses (HAV and HEV) are the most common etiologies of viral hepatitis in India. To better understand the epidemiology of these infections, laboratory surveillance data generated during 2014–2017, by a network of 51 virology laboratories, were analyzed. Among 24,000 patients tested for both HAV and HEV, 3,017 (12.6%) tested positive for HAV, 3,865 (16.1%) for HEV, and 320 (1.3%) for both HAV and HEV. Most (74.6%) HAV patients were aged ≤ 19 years, whereas 76.9% of HEV patients were aged ≥ 20 years. These laboratories diagnosed 12 HAV and 31 HEV clusters, highlighting the need for provision of safe drinking water and improvements in sanitation. Further expansion of the laboratory network and continued surveillance will provide data necessary for informed decision-making regarding introduction of hepatitis-A vaccine into the immunization program.

1 January 2015 in Indian Journal of Burns
Verified
Journal Article
Open access
PDF file
PBPuneet Bhatt
Puneet Bhatt
KRKhushi Ram Rathi
Khushi Ram Rathi
SHSantanu Hazra
Santanu Hazra
ASAlok Sharma
Alok Sharma
VSVishal Shete
Vishal Shete
Background: Pseudomonas aeruginosa is an important cause of hospital acquired infection especially in patients admitted in critical care units such as intensive care units and burn care units. Because of its considerable potential to become resistant to important anti-pseudomonal agents, infection of burn wounds by P. aeruginosa, especially by multi-drug resistant (MDR) strains has become a major problem. Aim: This study was carried with an aim to determine the antimicrobial resistance pattern and prevalence of MDR P. aeruginosa infection among burns patients at a tertiary care center. Materials and Methods: This cross-sectional study was carried out from June 2013 to July 2014 in microbiology laboratory of a tertiary care center. In this study, 102 nonrepetitive clinical samples from patients admitted in burn unit were collected and the isolates were identified by conventional phenotypic methods. The antibiotic sensitivity testing of all P. aeruginosa isolates was done using Kirby-Bauer disc diffusion method and the results were interpreted according to the Clinical and Laboratory Standards Institute guidelines. Results: Out of 102 clinical samples, P. aeruginosa was isolated from 56 (54.9%) samples. Out of these 56 isolates, 43 (76.8%) isolates were MDR. Majority of the isolates were resistant to amikacin (73.2%), gentamicin (84%), tobramycin (75%), ceftazidime (76.79%), ciprofloxacin (71.4%), cefepime (64.6%), piperacillin (80.36%) and imipenem (61%). Conclusion: The prevalence of P. aeruginosa infection in patients admitted in burns unit was found to be 54.9%. This study showed an increased prevalence (76.8%) of MDR P. aeruginosa infection in burn patients.

1 November 2015 in New Microbes and New Infections
Verified
Journal Article
Open access
PBPuneet Bhatt
Puneet Bhatt
KTKundan Tandel
Kundan Tandel
VSVishal Shete
Vishal Shete
KRK.R. Rathi
K.R. Rathi
The emergence of resistance to multiple antimicrobial agents in Gram-negative bacteria is a significant threat to public health, as it restricts the armamentarium of the clinician against these infections. The aim of this study was to determine the burden of extensively drug-resistant (XDR) and pandrug-resistant (PDR) Gram-negative bacteria at a tertiary-care centre. Antimicrobial susceptibility testing of 1240 clinical isolates of Gram-negative bacteria obtained from various clinical samples during the study period was carried out by the Kirby-Bauer disc diffusion method. Minimum inhibitory concentration of all antibiotics including tigecycline and colistin was determined by Vitek-2 automated susceptibility testing system. Out of 1240 isolates of Gram-negative bacteria, 112 isolates (9%) were resistant to all the antibiotics tested by Kirby-Bauer disc diffusion method. This finding was corroborated by Vitek-2. In addition, Vitek-2 found that 67 isolates were resistant to all antibiotics except tigecycline and colistin. A total of 30 isolates were susceptible to only colistin, and four isolates were susceptible to only tigecycline. It was also found that six isolates (excluding five isolates of Proteus spp.) were resistant to both colistin and tigecycline. Thus, 101 (8.1%) out of 1240 isolates were XDR and 11 isolates (0.9%) were PDR. The findings of this study reveal increased burden of XDR and PDR Gram-negative bacteria in our centre. It also highlights the widespread dissemination of these bacteria in the community. This situation warrants the regular surveillance of antimicrobial resistance of Gram-negative bacteria and implementation of an efficient infection control program.

24 December 2017 in Journal of Pathogens
Verified
Journal Article
Open access
PDF file
VSVishal Shete
Vishal Shete
NGNaveen Grover
Naveen Grover
MKMahadevan Kumar
Mahadevan Kumar
Enzymatic modification results in high-level resistance to aminoglycoside (HLAR), which eliminates the synergistic bactericidal effect of combined exposure to a cell wall-active agent and an aminoglycoside. So aim of the study was to determine prevalence of HLAR enterococcal isolate and to study distribution of aminoglycoside modifying enzyme genes in them. A total of 100 nonrepeat isolates of enterococci from various clinical samples were analyzed. As per Clinical and Laboratory Standards Institute guidelines enterococci were screened for HLAR by Kirby-Bauer disc diffusion method. Minimum inhibitory concentration of all isolates for gentamicin and streptomycin was determined by E-test. Multiplex polymerase chain reaction (PCR) was carried out for HLAR enterococcal isolates to identify aminoglycoside modifying enzymes genes responsible for resistance. 60% isolates were found to be high-level gentamicin resistant (HLGR) whereas 45% isolates were found to be high-level streptomycin resistant (HLSR). By multiplex PCR 80% HLGR isolates carried bifunctional aminoglycoside modifying enzyme geneaac(6′)-Ie-aph(2′′)-Iawhereas 18 out of 45 high-level streptomycin resistant, that is, 40%, isolates carriedaph(3′)-IIIa.However,aph(2′′)-Ib, aph(2′′)-Ic, aph(2′′)-Id,andant(4′)-Iagenes which encode other aminoglycosides modifying enzymes were not detected. Bifunctional aminoglycoside modifying enzyme geneaac(6′)-Ie-aph(2′′)-Iais the predominant gene responsible for HLAR.

31 January 2019 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MMManoj Vasant Murhekar
Manoj Vasant Murhekar
KKK Kanagasabai
K Kanagasabai
VSVishal Shete
Vishal Shete
VJVasna Joshua
Vasna Joshua
MRM Ravi
M Ravi
NGNivedita Gupta
Nivedita Gupta
Background: We analysed the laboratory surveillance data generated by the network of virology laboratories from January 2016 to July 2018 to describe the epidemiology of chikungunya in India. Methods: Suspected patients reporting to virology laboratories are investigated for the presence of immunoglobulin M (IgM) antibodies against chikungunya virus (CHIKV) as evidence of recent infection. We analysed the data to describe the distribution of seropositive individuals by time, place and demographic characteristics. Results: Of the 49 380 sera tested from suspected patients, 20.5% were seropositive. CHIKV IgM positivity was seen throughout the year, with a peak between September and December. The laboratories diagnosed 28 outbreaks of chikungunya during the study period. Conclusions: Laboratory surveillance data indicate continued transmission of CHIKV in many regions of India.